Plasma reagent kit

for molecular biologyIgGIgM

Scope of the "SARS-CoV-2 IgM / IgG Screen" reagent ELISA Diagnosis of COVID-19 in Patients with Acute Respiratory Syndrome Identification of asymptomatic and erased forms of COVID-19 in the foci of the disease, examination of those in contact with infected SARS-CoV-2 Examination of persons arriving from regions with a high level of COVID-19 disease and their re-examination before leaving the observation Identification of COVID-19 patients, regardless of the form of the infectious process Identification of potential donors of high-titer plasma that can be used in the treatment of severe forms of COVID-19 RU, RZN2020 / 11864 on the territory of the Russian Federation SARS-CoV-2 IgM / IgG Screen" reagents set (diagnosis of COVID-19) is significantly cheaper than molecular tests and can be used for large-scale studies to determine the true lethality and dynamics of the spread of SARS-CoV-2, which will contain the spread of the pathogen COVID -19 after the termination of quarantine measures.